COVID-19 Pfizer vaccines for children appear to be safe and nearly 91% effective at preventing symptomatic infections in kids aged 5-11, according to details of a study released Friday.
The FDA is currently debating whether to authorize vaccinations to that group. Advisers will publicly debate the evidence next week, and pending the authorization of the shot, the Centers for Disease Control and Prevention will decide who should receive them.
Shots could be available for kids as early as November.
